CoChat

Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity

Open access
Fu, Zhiyao, Berhane, Feven, Fite, Alemu, Seyoum, Berhane, Abou-Samra, Abdul B., Zhang, Ren · 2014 · Scientific Reports

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Lipasin (also known as C19ORF80, RIFL, ANGPTL8 and betatrophin) is a newly discovered circulating factor that regulates lipid metabolism and promotes pancreatic β-cell proliferation. Whether circulating levels of lipasin in humans are altered in a) type 2 diabetes; b) obesity and c) the postprandial state, however, is unknown. The current study aimed to compare serum lipasin levels in those who were a) non-diabetic (N=15) or diabetic (BMI- and age-matched; N=14); b) lean or obese (N=53 totally) and c) fasting and 2 hours following a defined meal (N=12). Serum lipasin levels were determined by the enzyme-linked immunosorbent assay. Lipasin levels [mean±SEM] were increased by more than two fold (P<0.001) in the diabetic patients (5.56±0.73 ng/mL) as compared to the control subjects (2.19±0.24 ng/mL). Serum lipasin levels were positively correlated with BMI (rho=0.49, P<0.001), and showed a 35% increase 2 hours following a defined meal (P=0.009). Therefore, lipasin/betatrophin is nutritionally-regulated hepatokine that is increased in human type 2 diabetes and obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep05013

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Serum levels of lipasin are elevated in patients with type 2 diabetes. A) Characterization of the standard curve for the lipasin ELISA kit. B) Serum lipasin levels are elevated in patients with type 2 diabetes. Box plot for lipasin levels in non-diabetic and diabetic subjects. Lipasin ELISA was performed using serum samples from overnight fasted non-diabetic (n = 15) and diabetic subjects (n = 14). Boxes represent the interquartile range between first and third quartiles, and the line (square) inside represents the median (mean). P values were obtained by performing Student t tests. C) Correlation between serum lipasin and fasting glucose levels determined by Spearman's rank correlation. D) The promoter sequence of human lipasin and consensus binding site of ChREBP. The ChREBP consensus site is adapted from ref. 17.
Figure 1 Serum levels of lipasin are elevated in patients with type 2 diabetes. A) Characterization of the standard curve for the lipasin ELISA kit. B) Serum lipasin levels are elevated in patients with type 2 diabetes. Box plot for lipasin levels in non-diabetic and diabetic subjects. Lipasin ELISA was performed using serum samples from overnight fasted non-diabetic (n = 15) and diabetic subjects (n = 14). Boxes represent the interquartile range between first and third quartiles, and the line (square) inside represents the median (mean). P values were obtained by performing Student t tests. C) Correlation between serum lipasin and fasting glucose levels determined by Spearman's rank correlation. D) The promoter sequence of human lipasin and consensus binding site of ChREBP. The ChREBP consensus site is adapted from ref. 17.CC BY-NC-SA · PubMed Central
Figure 2 Serum levels of lipasin are elevated in obesity, and are positively correlated to BMI. A) Serum lipasin levels are elevated in obesity. Serum lipasin levels were examined using ELISA. Box plot for lipasin levels in lean (BMI < 25) and overweight or obese human subjects (BMI ≥ 25). Lipasin ELISA was performed using serum samples from overnight fasted lean (n = 24) and overweight or obese subjects (n = 29). Boxes represent the interquartile range between first and third quartiles, and the line (square) inside represents the median (mean). P values were obtained by performing Student t tests. B) Serum lipasin levels are positively correlated with BMI determined by Spearman's rank correlation.
Figure 2 Serum levels of lipasin are elevated in obesity, and are positively correlated to BMI. A) Serum lipasin levels are elevated in obesity. Serum lipasin levels were examined using ELISA. Box plot for lipasin levels in lean (BMI < 25) and overweight or obese human subjects (BMI ≥ 25). Lipasin ELISA was performed using serum samples from overnight fasted lean (n = 24) and overweight or obese subjects (n = 29). Boxes represent the interquartile range between first and third quartiles, and the line (square) inside represents the median (mean). P values were obtained by performing Student t tests. B) Serum lipasin levels are positively correlated with BMI determined by Spearman's rank correlation.CC BY-NC-SA · PubMed Central
Figure 3 Serum levels of lipasin are increased 2 hours following a defined meal. A) Serum lipasin levels were examined using ELISA. Serum samples were obtained from 12 lean human subjects after an overnight fast, without a meal or 2 hours following a defined meal. Refer to table 2 for meal nutritional composition. Each triangle denotes an individual, and the bars denote mean ± SEM. P values were obtained by performing paired Student t tests. B) Change in lipasin levels following the defined meal in each of the 12 individuals.
Figure 3 Serum levels of lipasin are increased 2 hours following a defined meal. A) Serum lipasin levels were examined using ELISA. Serum samples were obtained from 12 lean human subjects after an overnight fast, without a meal or 2 hours following a defined meal. Refer to table 2 for meal nutritional composition. Each triangle denotes an individual, and the bars denote mean ± SEM. P values were obtained by performing paired Student t tests. B) Change in lipasin levels following the defined meal in each of the 12 individuals.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 22 references

Cited by

Items 101–200 of 230

Metadata

Authors
Fu, Z., Berhane, F., Fite, A., Seyoum, B., Abou-Samra, A. B., & Zhang, R.
Affiliations
Wayne State University (US)
Corresponding author
Zhang, Ren
Venue
Scientific Reports
Published
2014-05-23
Volume
4
Issue
1
Pages
5013-5013
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2154364167
Cited by
232
References
22
Citations by year
2026: 3 · 2025: 10 · 2024: 13 · 2023: 13 · 2022: 16 · 2021: 17 · 2020: 25 · 2019: 18 · 2018: 22 · 2017: 31 · 2016: 32 · 2015: 24 · 2014: 7
FWCI
23.66
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
Wayne State University (176412)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords
betatrophin, type 2 diabetes, obesity, hepatokines, postprandial lipemia, body mass index, pancreatic beta-cell proliferation, lipid metabolism, serum biomarkers
MeSH terms
Angiopoietin-like Proteins, Angiopoietin-Like Protein 8, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Male, Middle Aged, Obesity, Prognosis, Biomarkers, Case-Control Studies, Peptide Hormones

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.